Status: current, Defined. Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4592027018 | Amivantamab-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4592028011 | Product containing amivantamab (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Amivantamab-containing product | Is a | Monoclonal antibody antineoplastic agent | true | Inferred relationship | Some | ||
| Amivantamab-containing product | Is a | Protein-tyrosine kinase inhibitor-containing product | true | Inferred relationship | Some | ||
| Amivantamab-containing product | Is a | Epidermal growth factor receptor antagonist antineoplastic agent | true | Inferred relationship | Some | ||
| Amivantamab-containing product | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Amivantamab-containing product | Has active ingredient | Amivantamab | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Amivantamab only product | Is a | True | Amivantamab-containing product | Inferred relationship | Some | |
| Amivantamab-containing product in parenteral dose form | Is a | True | Amivantamab-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR